STX6 rs1411478 is not associated with increased risk of Parkinson's disease

Parkinsonism and Related Disorders

Volumn 19, Issue 5, 2013, Pages 563-565

  Trinh, Joanne ^a   Vilariño Güell, Carles ^a   Donald, Alan ^a   Shah, Brinda ^a   Yu, Irene ^a   Szu Tu, Chelsea ^a   Aasly, Jan O ^b   Wu, Ruey Meei ^c   Hentati, Faycal ^d   Rajput, Ali H ^e   Rajput, Alex ^e   Farrer, Matthew J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d Institut National de Neurologie Tunisia   (Tunisia)

^e SASKATOON HEALTH REGION   (Canada)

Author keywords

Parkinson's disease; Progressive supranuclear palsy; STX6; Syntaxin 6

Indexed keywords

SYNTAXIN; SYNTAXIN 6; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANADA; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PARKINSON DISEASE; PRIORITY JOURNAL; SYNTAXIN 6 GENE; TAIWAN; TUNISIA;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NORWAY; PARKINSON DISEASE; QA-SNARE PROTEINS; RISK FACTORS; TAIWAN; TUNISIA;

EID: 84875527997     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.01.019     Document Type: Article

References (24)

1. Farrer M.J. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006, 7:306-318.
2. Litvan I. Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep 2004, 4:296-302.
3. Ezquerra M., Pastor P., Gaig C., Vidal-Taboada J.M., Cruchaga C., Munoz E., et al. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy. Neurobiol Aging 2011, 32:547.e11-547.e16.
4. Wider C., Vilarino-Guell C., Jasinska-Myga B., Heckman M.G., Soto-Ortolaza A.I., Cobb S.A., et al. Association of the MAPT locus with Parkinson's disease. Eur J Neurol 2010, 17:483-486.
5. Hoglinger G.U., Melhem N.M., Dickson D.W., Sleiman P.M., Wang L.S., Klei L., et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 2011, 43:699-705.
6. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009, 41:1308-1312.
7. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat Rev Mol Cell Biol 2006, 7:631-643.
8. Burre J., Sharma M., Tsetsenis T., Buchman V., Etherton M.R., Sudhof T.C. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010, 329:1663-1667.
9. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005, 76:672-680.
10. Vilarino-Guell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., et al. VPS35 mutations in Parkinson disease. Am J Hum Genet 2011, 89:162-167.
11. Edvardson S., Cinnamon Y., Ta-Shma A., Shaag A., Yim Y.I., Zenvirt S., et al. A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism. PLoS One 2012, 7:e36458.
12. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
13. McGough I.J., Cullen P.J. Recent advances in retromer biology. Traffic 2011, 12:963-971.
14. Mallard F., Tang B.L., Galli T., Tenza D., Saint-Pol A., Yue X., et al. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol 2002, 156:653-664.
15. Kuliawat R., Kalinina E., Bock J., Fricker L., McGraw T.E., Kim S.R., et al. Syntaxin-6 SNARE involvement in secretory and endocytic pathways of cultured pancreatic beta-cells. Mol Biol Cell 2004, 15:1690-1701.
16. Zimprich A., Benet-Pages A., Struhal W., Graf E., Eck S.H., Offman M.N., et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 2011, 89:168-175.
17. Pankratz N., Wilk J.B., Latourelle J.C., DeStefano A.L., Halter C., Pugh E.W., et al. Genome wide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 2009, 124:593-605.
18. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010, 42:781-785.
19. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009, 41:1303-1307.
20. Kametaka S., Moriyama K., Burgos P.V., Eisenberg E., Greene L.E., Mattera R., et al. Canonical interaction of cyclin G associated kinase with adaptor protein 1 regulates lysosomal enzyme sorting. Mol Biol Cell 2007, 18:2991-3001.
21. Seaman M.N., Harbour M.E., Tattersall D., Read E., Bright N. Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. J Cell Sci 2009, 122:2371-2382.
22. Igarashi M., Tagaya M., Komiya Y. The soluble N-ethylmaleimide-sensitive factor attached protein receptor complex in growth cones: molecular aspects of the axon terminal development. J Neurosci 1997, 17:1460-1470.
23. Kimura K., Mizoguchi A., Ide C. Regulation of growth cone extension by SNARE proteins. J Histochem Cytochem 2003, 51:429-433.
24. Tang B.L., Tan A.E., Lim L.K., Lee S.S., Low D.Y., Hong W. Syntaxin 12, a member of the syntaxin family localized to the endosome. J Biol Chem 1998, 273:6944-6950.